Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | -3.41% | -7.04% | -60.16% |
05-02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
05-02 | CROSSJECT : We welcome the securing of the group’s financial needs | AL |
Business Summary
Number of employees: 110
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Needle-free Injection System
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +4.61% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +4.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 07/08/01 | |
Olivier Giré
PRN | Corporate Officer/Principal | - | 31/12/15 |
Corporate Officer/Principal | - | 31/12/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Teper
BRD | Director/Board Member | 64 | 06/06/23 |
Eric Nemeth
BRD | Director/Board Member | 65 | - |
Philippe Monnot
CHM | Chairman | 65 | - |
Yannick Plétan
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,763,256 | 22,491,997 ( 61.18 %) | 0 | 61.18 % |
Stock B | 0 | 1,655,925 | 0 | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CROSSJECT 0.29% | 106,603 | 0.29% | 362,663 $ |
Company contact information
Crossject SA
6, rue Pauline Kergomard ZAC Parc Mazen Sully
21000, Dijon
+33 3 80 54 98 50
http://www.crossject.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.16% | 83.26M | |
-4.36% | 205M |
- Stock Market
- Equities
- ALCJ Stock
- Company Crossject